|
|
| |
| |
Research
& Reviews
in
BioSciences |
December 2009
Volume 3(4) |
|
|
|
|
|
|
| |
|
Efficacy Of Bark And Leaf
Extracts Of Zizyphus Rugosa Lam. Against
Clinical Bacterial Isolates
|
|
K.S. Vinayaka1*, S. Shravanakumar1, A.C.
Roopashree1, Sandeep M. Otari1,
S.V. Praveen Kumar2, D. Swathi3, T.R. Prashith
Kekuda3
1Dept. of Studies and Research in Applied Botany,
Jnanasahyadri, Kuvempu University Shankaraghatta-577451, Karnataka
2Dept. of Studies and Research in Microbiology,
Shivagangothri, Tholahunse,
Davangere, Karnataka
3Dept. of Microbiology, S.R.N.M.N College of Applied
Sciences, NES Campus,
Balraj Urs Road, Shivamogga-577201, Karnataka |
| |
|
|
In the present study, the
phytoconstituents and antibacterial activity of methanol, chloroform and
hexane extracts of bark and leaf of Zizyphus rugosa Lam. was
investigated against two pathogens, namely Staphylococcus aureus
and Escherichia coli, isolated from clinical specimens were
studied. Preliminary phytochemical tests showed the presence of tannins,
alkaloids, steroids, saponins and flavonoids in methanol extract of
leaves while terpenoids, alkaloids, steroids and saponins were detected
in bark extract. All the solvent extracts exhibited antibacterial
activity as revealed by zone of inhibition formed around the well. Among
isolates subjected, marked inhibition of S. aureus was observed
at lesser concentration than E. coli. The leaf extracts were found to
inhibit test bacteria at low concentration than bark extracts. Overall,
among extracts tested, methanol extract was found to be more potent than
other extracts. Methanol and chloroform extracts of leaf and bark
inhibited S. aureus at a concentration of 2.5mg/ml while hexane extract
revealed MIC of 5mg/ml concentration. The antimicrobial activity of
solvent extracts of leaf and bark of Z. rugosa might be possibly due to
the presence of the phytoconstituents in the extracts. Since the study
involved the clinical isolates, which are among most noted antibiotic
resistant bacteria, the extracts could be useful in the treatment of the
infections caused by these bacteria. Further experiments are to be
conducted to isolate active principles from the extracts and to
determine in vivo antibacterial efficacy of phytoconstituents
against antibiotic resistant clinical pathogens. |
|
|
|
|
| |
|